New findings about how RBM10 inhibits lung cancer growth offers potential for an anti-cancer drug and more personalised treatment.
List view / Grid view
New understanding of how lung cancer cells become more aggressive when nutrient deprived could lead to novel combination treatments.
Lactate producing bacteria is responsible for rewiring metabolic signalling pathways, causing resistance to radiation therapy.
US study uncovers the best way to treat recurrent or progressive brain metastases using an amino acid PET technique.
Researchers from China have formulated a robotics system that can access areas in the lung non-invasively before cancer diagnosis.
US researchers found that the severity of muscle wasting from cancer is related to the type, size and location of the tumour, in mice.
Researchers have discovered a new cancer immunotherapy approach that shrinks solid tumours.
Researchers found that fibroblasts had varying effects on tumour cells based on both the type of non-small cell lung cancer and the drug used for treatment.
Researchers have developed a two-step approach using whole exome sequencing to focus on genes and pathways that predict whether cancer patients will respond to immunotherapy.
A new study from the University of Michigan Rogel Cancer Center, US has revealed that a cytokine and a fatty acid can work together to trigger ferroptosis. Here, Dr Weiping Zou, the lead researcher from the study, outlines how this process could be used to target cancer cells and enhance immunotherapies.
A new study has highlighted an enzyme called ART1 as a promising target for immunity-boosting cancer treatments.
The new study looked at the network of gene-gene interactions associated with cancer onset and progression to identify therapeutic targets.